MedTrace Logo

A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China

NCT05341128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1477

Last updated 2026-01-21

No results posted yet for this study

Summary

The main purpose is to describe how many children were treated during 24 months or less because of CPP and how treatment worked for them.

There are no participants in this trial, the study only involves reviewing participants medical past and current records and collecting information.

Conditions

  • Central Precocious Puberty

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2025-08-27
Completion
2025-08-27

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05341128 on ClinicalTrials.gov